Additional Shares

 
News Articles for Additional Shares top ^
2014/3/26
Alnylam Pharmaceuticals, Inc .
Sign-up for Genzyme Exercises its Right to Purchase Additional Shares of Alnylam Common Stock investment picks
2014/4/7
Marchex, Inc. (NASDAQ:MCHX) today announced the sale of additional shares of Class B common stock pursuant to the underwriters’ exercise in full of their option to purchase additional shares related to the Company’s previously announced registered public offering of 5,714,000 shares that closed on April 1, 2014.
Sign-up for Marchex Announces Underwriters’ Exercise of Option to Purchase Additional Shares investment picks
2013/12/9
HAMPTON, N.J., Dec.
Sign-up for Celldex Announces Exercise of Underwriters' Option to Purchase Additional Shares investment picks
2013/7/26
NEW YORK, July 26, 2013 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX) , an innovative, clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs, today announced that the underwriters have exercised in full their option to purchase an additional 855,000 shares of common stock.
Sign-up for TG Therapeutics, Inc. Announces Exercise of Option to Purchase Additional Shares investment picks
2013/12/23
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tcelna®, a patient-specific T-cell immunotherapy for the treatment of multiple sclerosis (MS), today announced the closing of the previously announced underwritten public offering of 4,120,000 shares of its common stock, including the full exercise of the over-allotment option granted to the underwriters to purchase an additional 618,000 shares of its common stock, at a price to the public of $1.70 per share.
Sign-up for Opexa Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares investment picks
Cousins Properties Incorporated (the “Company”) (NYSE: CUZ) today announced the completion of its public offering of 60,000,000 shares of the Company’s common stock, plus an additional 9,000,000 shares of the Company’s common stock issued and sold pursuant to the exercise of the underwriters’ option to purchase additional shares in full, at the public offering price of $10.00 per share.
Sign-up for Cousins Properties Completes Offering of Common Stock, Announces Exercise of Option to Purchase Additional Shares investment picks
2014/1/27
Full Circle Capital Corporation (NASDAQ:FULL) (“Full Circle”) today announced the full exercise of the option granted to the underwriters to purchase additional shares of Full Circle’s common stock in connection with its previously announced public offering of 1,650,000 shares, which closed on January 17, 2014.
Sign-up for Full Circle Capital Announces Full Exercise of Option to Purchase Additional Shares of Common Stock investment picks
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced that the underwriters for its recent follow-on offering have exercised their option to purchase additional shares and purchased an additional 407,403 shares in the offering.
Sign-up for Tetraphase Pharmaceuticals Announces Exercise of Underwriters’ Option to Purchase Additional Shares in Follow-On Offering investment picks
2014/1/29
KANSAS CITY, Kan.
Sign-up for Aratana Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares investment picks
Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud software solutions for life sciences, today announced the closing of its previously announced initial public offering of 15,001,750 shares of its Class A common stock at a price to the public of $20.00 per share, which included 1,956,750 shares issued upon the exercise in full of the underwriters’ option to purchase additional shares.
Sign-up for Veeva Systems Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares investment picks
2014/3/26
Amber Road, Inc. (NYSE: AMBR) , a leading provider of global trade management (GTM) solutions, today announced the closing of its previously announced initial public offering of 8,500,299 shares of its common stock at a price to the public of $13.00 per share, which included 1,108,734 shares issued upon the exercise in full of the underwriters’ option to purchase additional shares.
Sign-up for Amber Road Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Share investment picks
GlycoMimetics, Inc. (NASDAQ: GLYC) today announced the closing of its initial public offering of 8,050,000 shares of its common stock at an initial public offering price of $8.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 1,050,000 additional shares of common stock.
Sign-up for GlycoMimetics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares investment picks
2014/1/28
Hudson Pacific Properties, Inc. (the “Company”) (NYSE: HPP) today announced the completion of its public offering of 9,487,500 shares of its common stock (including 1,237,500 shares of its common stock issued and sold pursuant to the exercise of the underwriters’ option to purchase additional shares in full) at the public offering price of $21.50 per share.
Sign-up for Hudson Pacific Properties, Inc. Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares investment picks
2014/2/12
Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced that the underwriters for its public offering of 979,592 shares of its common stock at $122.50 per share have elected to exercise in full their option to purchase up to an additional 146,938 shares of common stock at the public offering price, less the underwriting discount.
Sign-up for Puma Biotechnology Announces Underwriters’ Full Exercise of Option to Purchase Additional Shares investment picks
2014/2/11
CAMBRIDGE, Mass.
Sign-up for Epizyme Announces Exercise of Underwriters' Option to Purchase Additional Shares of Common Stock investment picks
2014/3/17
Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, today announced the underwriters’ full exercise of the option granted to the underwriters to purchase an additional 786,750 shares of the company’s common stock, at a price to the public of $9.15 per share.
Sign-up for Ignyta Announces Underwriters’ Full Exercise of Option to Purchase Additional Shares in Public Offering of Common Stock investment picks
2014/3/21
NEW YORK , March 21, 2014 /PRNewswire/ -- ING U.S., Inc. (NYSE: VOYA) , which will rebrand as Voya Financial, Inc. in 2014, announced today that the underwriters in ING Group's public offering of 26,500,000 shares of ING U.S. common stock have exercised in full their option to purchase 3,975,000 additional shares from ING Group.
Sign-up for Underwriters of ING Group Offering of ING U.S. Common Stock to Acquire Approximately 4 Million Additional Shares investment picks
2014/3/19
Castlight Health, Inc. (NYSE: CSLT), a leading provider of enterprise healthcare cloud software, today announced it has closed its previously announced initial public offering of 12,765,000 shares of its Class B common stock at a price to the public of $16.00 per share, which included 1,665,000 shares issued upon the exercise in full of the underwriters’ option to purchase additional shares.
Sign-up for Castlight Health Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares investment picks
2014/3/31
Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud software solutions for life sciences, today announced the closing of its previously announced underwritten public offering of 13,800,000 shares of its Class A common stock at a price to the public of $26.35 per share, which included 1,800,000 shares issued upon the exercise in full of the underwriters’ option to purchase additional shares.
Sign-up for Veeva Systems Announces Closing of Follow-on Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Additional Shares
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Additional Service  |  Next: Additional Stock